Two more firms contact Drap for vaccine registration

Published January 22, 2021
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File

ISLAMABAD: While three foreign pharmaceutical companies have already developed their stakes in Pakistan, two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines.

On Thursday, 2,363 new cases and 54 deaths were reported due to coronavirus in a single day as the number of active cases reached 35,293 across the country.

An official of the Ministry of National Health Services (NHS) said that Russia’s state-owned Sputnik-V company has filed an application seeking permission for emergency use of its vaccine in Pakistan.

“It is a double-dose vaccine and will be administered by syringes,” he said.

“Moreover, Chinese firm Anhui Zheifi Longcom Biopharmaceuticals Company Limited has applied for phase-III clinical trial of its vaccine in Pakistan. The vaccine has been jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences,” the official said.

Earlier, three firms had developed their interests in Pakistan as British firm Oxford-AstraZeneca and Chinese firm Sinopharm’s vaccines were registered with Drap. The third firm namely CanSino Biologics is also a Chinese firm and it has been conducting phase-III clinical trial of its vaccine in Pakistan.

54 die of Covid-19 in a single day in Pakistan

“Oxford-AstraZeneca’s vaccine will be received through the international alliance Covax and also through a private channel. Pakistan has pre-booked 1.1 million doses of Sinopharm’s vaccine,” the official said.

Meanwhile, Usman Ghani, a representative of Sindh Medical Store which has got Oxford-AstraZeneca vaccine registered with Drap, said the manufacturer had not given any timeline for supplying the vaccine because of priorities set by the Indian government for local preferences.

According to data of the National Command and Operation Centre, as many as 2,363 people were infected with coronavirus and 54 died due to Covid-19 in a single day. While there were 324 ventilators in use of Covid-19 patients, Multan’s 49 per cent, Islamabad’s 40pc, Lahore’s 37pc and Peshawar’s 30pc vents were in use.

Published in Dawn, January 22nd, 2021

Opinion

Editorial

Stock market carnage
Updated 04 Dec 2021

Stock market carnage

PAKISTAN’S stock market has been on a downward ride for the last several months as a result of deteriorating...
04 Dec 2021

Omicron threat

THE NCOC has suggested installing more oxygen plants in various parts of the country as the new Covid-19 variant,...
04 Dec 2021

UK spymaster speaks

A RECENT speech by the chief of MI6 — the UK’s external intelligence agency — provided a key insight into the...
Crime against humanity
Updated 03 Dec 2021

Crime against humanity

The government has yet to fulfil its long-standing pledge to criminalise enforced disappearances.
03 Dec 2021

Revised valuations

THE revised property valuations notified by the FBR for 40 cities for the purpose of collecting federal taxes —...
03 Dec 2021

PWD await rights

ON the International Day of Disabled Persons, it is important to take stock of how far Pakistan has come in ensuring...